Boston Scientific (BSX) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter increased compared with the same quarter one year earlier. However, revenue decreased from the immediately preceding quarter.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter increased compared with the same quarter one year earlier. However, revenue decreased from the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$3.5B
Revenue reported for this quarter.
Quarter-over-quarter
-2.0%
Change from the immediately preceding quarter.
Year-over-year
+11.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$13.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $3.2B | +3.7% |
| Mar 31, 2023 | $3.4B | +12.0% |
| Jun 30, 2023 | $3.6B | +10.9% |
| Sep 30, 2023 | $3.5B | +11.3% |
Revenue performance
The reported revenue reflected growth from the prior year, driven by both the MedSurg and Cardiovascular segments.
Quarterly comparison
Compared with the previous quarter, revenue declined. Relative to the same period a year ago, revenue was higher.
What to watch
Observe the quarter-over-quarter decline following several consecutive quarters of growth.